Literature DB >> 21838843

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers.

Elias Dakwar1, Edward V Nunes, Adam Bisaga, Kenneth C Carpenter, John P Mariani, Maria A Sullivan, Wilfrid N Raby, Frances R Levin.   

Abstract

Depressive symptoms often coexist with substance use disorders (SUDs). The DSM-IV has identified two distinct categories for depression coexisting with SUDs-independent depression and substance-induced depression. While this distinction has important therapeutic and prognostic implications, it remains difficult to make in clinical practice; the differentiation is often guided by chronological and symptom severity criteria that patients may be unable to precisely provide. Furthermore, it is unclear whether the various substances commonly abused-cannabis, cocaine, and opioids-are equally associated with the two types of depression. Predictors, associations, and other markers may be helpful in guiding the diagnostic process. We, therefore, examined the differences between cannabis-, cocaine-, and opioid-dependent individuals contending with independent depression and those contending with substance-induced depression in regard to several variables, hypothesizing that independent depression is more commonly found in females, and that it is associated with higher symptom severity and psychiatric comorbidity. Cocaine-, cannabis-, and/or opioid-dependent, treatment-seeking individuals underwent a structured clinical interview for DSM-IV-TR disorders after providing consent at our clinical research site; those with co-existing primary depression or substance-induced depression diagnoses were provided with further questionnaires and were entered into this analysis (n= 242). Pair-wise comparisons were conducted between the groups classified as independent versus substance-induced depression with 2-by-2 tables and chi-square tests for dichotomous independent variables, and t-tests for continuous variables. Binomial logistic regression was performed in order to ascertain which of the variables were significant predictors. Women were more likely than men to have independent depression (p< .005). Cannabis dependence was highly associated with independent depression (p< .001), while cocaine dependence was highly associated with substance-induced depression (p< .05). Independent depression was associated with higher Hamilton depression scale scores (16 vs. 10, p< .005), and was more highly associated with the comorbid diagnosis of posttraumatic stress disorder (p< .05). Cannabis dependence (p< .001) and female gender (p< .05) were highly significant predictors of major depression specifically. Gender, cannabis dependence, psychiatric severity, and psychiatric comorbidity have variable, statistically significant associations with independent and substance-induced depression, and may be helpful in guiding the diagnostic process. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2011        PMID: 21838843      PMCID: PMC3600842          DOI: 10.1111/j.1521-0391.2011.00148.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  13 in total

1.  Comparison of induced and independent major depressive disorders in 2,945 alcoholics.

Authors:  M A Schuckit; J E Tipp; M Bergman; W Reich; V M Hesselbrock; T L Smith
Journal:  Am J Psychiatry       Date:  1997-07       Impact factor: 18.112

2.  Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression.

Authors:  Adam M Leventhal; Marc E Mooney; Katherine A DeLaune; Joy M Schmitz
Journal:  Am J Addict       Date:  2006 Sep-Oct

3.  Effects of major depression on remission and relapse of substance dependence.

Authors:  Deborah Hasin; Xinhua Liu; Edward Nunes; Steven McCloud; Sharon Samet; Jean Endicott
Journal:  Arch Gen Psychiatry       Date:  2002-04

4.  Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.

Authors:  Edward V Nunes; Xinhua Liu; Sharon Samet; Karen Matseoane; Deborah Hasin
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

5.  Gender differences in depression: findings from the STAR*D study.

Authors:  Sheila M Marcus; Elizabeth A Young; Kevin B Kerber; Susan Kornstein; Amy H Farabaugh; Jeff Mitchell; Stephen R Wisniewski; G K Balasubramani; Madhukar H Trivedi; A John Rush
Journal:  J Affect Disord       Date:  2005-08       Impact factor: 4.839

Review 6.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

Review 7.  Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.

Authors:  J M Kent; J D Coplan; J M Gorman
Journal:  Biol Psychiatry       Date:  1998-11-01       Impact factor: 13.382

8.  A comparison of factors associated with substance-induced versus independent depressions.

Authors:  Marc A Schuckit; Tom L Smith; George P Danko; Juliann Pierson; Ryan Trim; John I Nurnberger; John Kramer; Samuel Kuperman; Laura J Bierut; Victor Hesselbrock
Journal:  J Stud Alcohol Drugs       Date:  2007-11       Impact factor: 2.582

9.  Substance-induced and independent major depressive disorder in treatment-seeking alcoholics: associations with dysfunctional attitudes and coping.

Authors:  Christopher W Kahler; Susan E Ramsey; Jennifer P Read; Richard A Brown
Journal:  J Stud Alcohol       Date:  2002-05

10.  Subtypes of major depression in substance dependence.

Authors:  Mark J Niciu; Grace Chan; Joel Gelernter; Albert J Arias; Kara Douglas; Roger Weiss; Raymond F Anton; Lindsay Farrer; Joseph F Cubells; Henry R Kranzler
Journal:  Addiction       Date:  2009-08-04       Impact factor: 6.526

View more
  10 in total

1.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

2.  Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.

Authors:  Tessa Frohe; Cheryl L Beseler; Andres M Mendoza; Linda B Cottler; Robert F Leeman
Journal:  J Consult Clin Psychol       Date:  2019-10

3.  Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Authors:  Eduardo Roque Butelman; Silvia Bacciardi; Angelo Giovanni Icro Maremmani; Maya Darst-Campbell; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Am J Addict       Date:  2017-06-27

4.  "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".

Authors:  Marta Valenza; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2017-05-27       Impact factor: 4.530

5.  Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems.

Authors:  Katherine Sanchez; Robrina Walker; Aimee N C Campbell; Tracy L Greer; Mei-Chen Hu; Bruce D Grannemann; Edward V Nunes; Madhukar H Trivedi
Journal:  Subst Abus       Date:  2014-08-01       Impact factor: 3.716

6.  Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.

Authors:  Perrine Roux; Caroline Lions; Julien Cohen; Maria Winnock; Dominique Salmon-Céron; Firouze Bani-Sadr; Philippe Sogni; Bruno Spire; François Dabis; Maria Patrizia Carrieri
Journal:  Antivir Ther       Date:  2013-10-28

7.  Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.

Authors:  Rachel L Tomko; Nathaniel L Baker; Caitlyn O Hood; Amanda K Gilmore; Erin A McClure; Lindsay M Squeglia; Aimee L McRae-Clark; Susan C Sonne; Kevin M Gray
Journal:  Psychopharmacology (Berl)       Date:  2019-11-11       Impact factor: 4.530

8.  Substance type moderates the longitudinal association between depression and substance use from pre-treatment through a 1-year follow-up.

Authors:  Deepika Anand; Catherine Paquette; Anna Bartuska; Stacey B Daughters
Journal:  Drug Alcohol Depend       Date:  2019-02-05       Impact factor: 4.492

Review 9.  The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.

Authors:  Philip J Freda; Jason H Moore; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

10.  Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).

Authors:  Perrine Roux; Caroline Lions; Antoine Vilotitch; Laurent Michel; Marion Mora; Gwenaelle Maradan; Fabienne Marcellin; Bruno Spire; Alain Morel; Patrizia M Carrieri
Journal:  Harm Reduct J       Date:  2016-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.